Livzon Information_Livzon Pharmaceutical Group Inc.

News Center

New Lijuzhu Magazine

Lizhu R&D has won another award

Lizhu R&D has won another award

Honesty is the principle of being a person, credit is the soul of society, and innovation is the foundation of enterprises. In the 33 years of the flowing river of Lizhu Pharmaceutical, the Lizhu Deler brand was established in 1989, and in 1999, the Shenqi Fuzheng injection was approved for formal production, subsequently winning the "First Prize for Scientific and Technological Progress in Guangdong Province and the Second Prize for National Scientific and Technological Progress"; in 2001, the antiviral granules won the "First Prize for Science and Technology from the Chinese Association of Traditional Chinese Medicine"; in 2005, Lishenbao (injectable urinary follicle-stimulating hormone) won the "Second Prize for Scientific and Technological Progress in Guangdong Province"; the original innovative drug Aiprazole also won the "First Prize for Scientific and Technological Progress in Guangdong Province and the Second Prize for National Scientific and Technological Progress".

2018-07-06

Congratulations! LIZHU Group has won the 19th China Patent Excellence Award.

Congratulations! LIZHU Group has won the 19th China Patent Excellence Award.

On the afternoon of June 14, the Zhuhai Science and Technology Innovation Conference was held in the Xingguang Conference Center on the first floor of the resort hotel in our city.     The meeting was presided over by Comrade Guo Yonghang, Secretary of the Zhuhai Municipal Committee, with the participation of Vice President Zhou Peng and Chief Scientist Wen Hong from the group.     The conference reported and commended the units in our city that won the 19th China Patent Award, among which the patent "Applications of Traditional Chinese Medicine Compositions in the Preparation of Drugs for Antiviral Treatment of Type 71 Enterovirus" from Livzon Pharmaceutical Group Co., Ltd. won the 19th China Patent Award.     Comrade Guo Yonghang personally awarded the prize to Chief Scientist Wen Hong of Livzon.     With the

2018-06-20

Lizhu won the "Most Beautiful Taxpayer" award.

Lizhu won the "Most Beautiful Taxpayer" award.

In the recently announced search for Zhuhai's "Most Beautiful Taxpayer" event, Livzon Pharmaceutical Group was elected. This large-scale event, jointly organized by the Zhuhai National Taxation Bureau, Zhuhai Television Station, and Zhuhai Special Zone Daily, has received widespread response from all sectors of society. After multiple evaluations, Livzon Pharmaceutical Group was rightfully recognized. Therefore, Zhuhai Television Station interviewed Livzon's Vice President Si Yanxia, who said: "We feel very honored that Livzon was able to win the title of 'Most Beautiful Taxpayer' in this event. We would like to take this opportunity to thank the event organizers, the Zhuhai National Taxation Bureau, and the citizens who actively voted for the candidate units for 'Most Beautiful Taxpayer'! Livzon is in Zhuhai.

2018-06-08

The Provincial Party School's training class visits Lizhu

The Provincial Party School's training class visits Lizhu

Persisting in the dual focus on party building leadership and enterprise operation is a main characteristic of the party building work in new economic organizations. The Party Committee of Lijuz Group has always integrated party building work into promoting enterprise development, not seeking formality but emphasizing effectiveness.  On May 22, students from the county (department) level training class of the Guangdong Provincial Party School visited Lijuz Group to conduct research on party building work. The group president Tao Desheng, the group party committee secretary and vice president Yang Daihong, the group party committee deputy secretary and vice president Zhou Peng, the group party office director and new Lijuz chief editor Liu Xibin, and the group party office deputy director and administrative headquarters vice general manager Wang Luhua received the visiting students. Lijuz started with Lijuz Dele and laid the foundation.

2018-05-23

[2018 Heavyweight Arrival] Injectable Esomeprazole Sodium Emerges

[2018 Heavyweight Arrival] Injectable Esomeprazole Sodium Emerges

近日，丽珠制药厂、丽珠医药研究所收到国家食品药品监督管理总局核准签发的《药品注册批件》（批件号：2017S00556）。注射用艾普拉唑钠历时9年研发，终于获批，为2018年开年的重磅好消息。

2018-01-10

The research on the injection of Ginseng and Astragalus for supporting the immune system has won the second prize in the National Science and Technology Progress Award.

The research on the injection of Ginseng and Astragalus for supporting the immune system has won the second prize in the National Science and Technology Progress Award.

On the morning of January 8, 2018, the 2017 National Science and Technology Awards Conference opened at the Great Hall of the People. Leaders of the Party and the country attended the conference and presented awards to researchers who won the National Highest Science and Technology Award, National Natural Science Award, National Technological Invention Award, National Science and Technology Progress Award, and International Science and Technology Cooperation Award. The field of traditional Chinese medicine achieved remarkable results again, with four achievements winning the National Science and Technology Progress Award! Among them, the project "Research and Application of Triterpenes and Their Saponin Components in Traditional Chinese Medicine and Natural Medicines" by Professor Ye Wencai's team from Jinan University won the second prize of the National Science and Technology Progress Award. The main research units of this project include Jinan University and China Pharmaceutical University.

2018-01-10

The LIZHU brand ranks 318th in the top 500 brand values.

On December 18, 2017, the China Brand Value 500 Strong Review Committee announced the 11th China Brand Value 500 Strong List for 2017. Lijuzhu Group ranked 318th in the China Brand Value 500 Strong.

2017-12-20

Double report and double approval, congratulations!

Double report and double approval, congratulations!

Recently, Zhuhai Lizhu Monoclonal Antibody Biotechnology Co., Ltd., a subsidiary of Lizhu Pharmaceutical Group Co., Ltd., received the "Drug Clinical Trial Approval" issued by the National Medical Products Administration (Approval No.: 2017L04883).  1. Main content of the drug approval Drug name: Recombinant Humanized Anti-PD-1 Monoclonal Antibody for Injection English name/Latin name: Recombinant Humanized anti-PD-1 Monoclonal Antibody for Injection Dosage form: Injection Specification: 50mg/

2017-11-06

< 1...11 12 13...25 > proceed page

Address: No.38, Chuangye North Road, Jinwan District, Zhuhai, Guangdong, P.R.China

京ICP备10002622号

Website :www.300.cn SEO [ Privacy Policy ]

Internet Drug Information Service Qualification Certificate: Guangdong-Non-Operating -2020-0186

Drug Business License: Guangdong AA7560155

Business License

Home | E-mail | Legal Statement

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.